IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,390,000 | +1088.2% | 1,000,000 | +72.7% | 5.90% | +957.0% |
| Q3 2022 | $3,231,000 | +43.1% | 579,061 | 0.0% | 0.56% | -7.5% |
| Q2 2022 | $2,258,000 | -72.2% | 579,061 | -60.7% | 0.60% | -65.7% |
| Q1 2022 | $8,127,000 | +66.5% | 1,475,000 | +157.5% | 1.76% | +84.9% |
| Q4 2021 | $4,881,000 | – | 572,862 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |